Adenosine monophosphate-activated protein kinase in diabetic nephropathy

Kidney Research and Clinical Practice

Volumn 35, Issue 2, 2016, Pages 69-77

  Kim, Yaeni ^a   Park, Cheol Whee ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

5 Adenosine monophosphate activated protein kinase; Cellular growth; Cellular metabolism; Diabetic nephropathy; Oxidative stress

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; 5' ADENOSINE MONOPHOSPHATE ACTIVATED PROTEIN KINASE; ADENOSINE PHOSPHATE; ADIPONECTIN; ADIPONECTIN RECEPTOR; ANTHOCYANIN; CINACALCET; FENOFIBRATE; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN KINASE; RESVERATROL; UNCLASSIFIED DRUG;

DIABETIC NEPHROPATHY; GLUCOSE HOMEOSTASIS; HUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

EID: 84967184685     PISSN: 22119132     EISSN: 22119140     Source Type: Journal    
DOI: 10.1016/j.krcp.2016.02.004     Document Type: Review

References (69)

1. W.C. Willett Dietary fat plays a major role in obesity: no Obes Rev 3 2002 59 68
2. L.S. Gross, L. Li, E.S. Ford, and S. Liu Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment Am J Clin Nutr 79 2004 774 779
3. B. Viollet, L. Lantier, J. Devin-Leclerc, S. Hebrard, C. Amouyal, R. Mounier, M. Foretz, and F. Andreelli Targeting the AMPK pathway for the treatment of type 2 diabetes Front Biosci (Landmark Ed) 14 2009 3380 3400
4. S. Dronavalli, I. Duka, and G.L. Bakris The pathogenesis of diabetic nephropathy Nat Clin Pract Endocrinol Metab 4 2008 444 452
5. C.W. Park Diabetic kidney disease: from epidemiology to clinical perspectives Diabetes Metab J 38 2014 252 260
6. D.G. Hardie, F.A. Ross, and S.A. Hawley AMPK: a nutrient and energy sensor that maintains energy homeostasis Nat Rev Mol Cell Biol 13 2012 251 262
7. K.R. Hallows, P.F. Mount, N.M. Pastor-Soler, and D.A. Power Role of the energy sensor AMP-activated protein kinase in renal physiology and disease Am J Physiol Renal Physiol 298 2010 F1067 F1077
8. M.Y. Kim, J.H. Lim, H.H. Youn, Y.A. Hong, K.S. Yang, H.S. Park, S. Chung, S.H. Ko, S.J. Shin, B.S. Choi, H.W. Kim, Y.S. Kim, J.H. Lee, Y.S. Chang, and C.W. Park Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in db/db mice Diabetologia 56 2013 204 217
9. U. Andersson, K. Filipsson, C.R. Abbott, A. Woods, K. Smith, S.R. Bloom, D. Carling, and C.J. Small AMP-activated protein kinase plays a role in the control of food intake J Biol Chem 279 2004 12005 12008
10. N. Kubota, W. Yano, T. Kubota, T. Yamauchi, S. Itoh, H. Kumagai, H. Kozono, I. Takamoto, S. Okamoto, T. Shiuchi, R. Suzuki, H. Satoh, A. Tsuchida, M. Moroi, K. Sugi, T. Noda, H. Ebinuma, Y. Ueta, T. Kondo, E. Araki, O. Ezaki, R. Nagai, K. Tobe, Y. Terauchi, K. Ueki, Y. Minokoshi, and T. Kadowaki Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake Cell Metab 6 2007 55 68
11. D.G. Hardie, J.W. Scott, D.A. Pan, and E.R. Hudson Management of cellular energy by the AMP-activated protein kinase system FEBS Lett 546 2003 113 120
12. S.A. Hawley, J. Boudeau, J.L. Reid, K.J. Mustard, L. Udd, T.P. Makela, D.R. Alessi, and D.G. Hardie Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade J Biol 2 2003 28
13. S.A. Hawley, M.A. Selbert, E.G. Goldstein, A.M. Edelman, D. Carling, and D.G. Hardie 5'-AMP activates the AMP-activated protein kinase cascade, and Ca2+/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms J Biol Chem 270 1995 27186 27191
14. M. Momcilovic, S.P. Hong, and M. Carlson Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro J Biol Chem 281 2006 25336 25343
15. D.G. Hardie, and M.L. Ashford AMPK: regulating energy balance at the cellular and whole body levels Physiology (Bethesda) 29 2014 99 107
16. B. Xiao, R. Heath, P. Saiu, F.C. Leiper, P. Leone, C. Jing, P.A. Walker, L. Haire, J.F. Eccleston, C.T. Davis, S.R. Martin, D. Carling, and S.J. Gamblin Structural basis for AMP binding to mammalian AMP-activated protein kinase Nature 449 2007 496 500
17. G.J. Gowans, S.A. Hawley, F.A. Ross, and D.G. Hardie AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation Cell Metab 18 2013 556 566
18. S. Horman, D. Vertommen, R. Heath, D. Neumann, V. Mouton, A. Woods, U. Schlattner, T. Wallimann, D. Carling, L. Hue, and M.H. Rider Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485/491 J Biol Chem 281 2006 5335 5340
19. M.J. Sanders, Z.S. Ali, B.D. Hegarty, R. Heath, M.A. Snowden, and D. Carling Defining the mechanism of activation of AMP-activated protein kinase by the small molecule A-769662, a member of the thienopyridone family J Biol Chem 282 2007 32539 32548
20. 2+ release Mol Metab 3 2014 742 753
21. G.J. Kops, T.B. Dansen, P.E. Polderman, I. Saarloos, K.W. Wirtz, P.J. Coffer, T.T. Huang, J.L. Bos, R.H. Medema, and B.M. Burgering Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress Nature 419 2002 316 321
22. S.B. Wu, Y.T. Wu, T.P. Wu, and Y.H. Wei Role of AMPK-mediated adaptive responses in human cells with mitochondrial dysfunction to oxidative stress Biochim Biophys Acta 1840 2014 1331 1344
23. A.M. Sanchez, A. Csibi, A. Raibon, K. Cornille, S. Gay, H. Bernardi, and R. Candau AMPK promotes skeletal muscle autophagy through activation of forkhead FoxO3a and interaction with Ulk1 J Cell Biochem 113 2012 695 710
24. G. Filomeni, E. Desideri, S. Cardaci, G. Rotilio, and M.R. Ciriolo Under the ROS.thiol network is the principal suspect for autophagy commitment Autophagy 6 2010 999 1005
25. H. Zrelli, M. Matsuoka, S. Kitazaki, M. Zarrouk, and H. Miyazaki Hydroxytyrosol reduces intracellular reactive oxygen species levels in vascular endothelial cells by upregulating catalase expression through the AMPK-FOXO3a pathway Eur J Pharmacol 660 2011 275 282
26. C. Canto, Z. Gerhart-Hines, J.N. Feige, M. Lagouge, L. Noriega, J.C. Milne, P.J. Elliott, P. Puigserver, and J. Auwerx AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity Nature 458 2009 1056 1060
27. T. Hayashi, M.F. Hirshman, E.J. Kurth, W.W. Winder, and L.J. Goodyear Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport Diabetes 47 1998 1369 1373
28. N. Ouchi, R. Shibata, and K. Walsh AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle Circ Res 96 2005 838 846
29. Y. Li, S. Xu, M.M. Mihaylova, B. Zheng, X. Hou, B. Jiang, O. Park, Z. Luo, E. Lefai, J.Y. Shyy, B. Gao, M. Wierzbicki, T.J. Verbeuren, R.J. Shaw, R.A. Cohen, and M. Zang AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice Cell Metab 13 2011 376 388
30. J.M. Weinberg Lipotoxicity Kidney Int 70 2006 1560 1566
31. H.N. Ginsberg Diabetic dyslipidemia: basic mechanisms underlying the common hypertriglyceridemia and low HDL cholesterol levels Diabetes 45 Suppl 3 1996 S27 S30
32. K. Stadler, I.J. Goldberg, and K. Susztak The evolving understanding of the contribution of lipid metabolism to diabetic kidney disease Curr Diab Rep 15 2015 40
33. S. Horman, G. Browne, U. Krause, J. Patel, D. Vertommen, L. Bertrand, A. Lavoinne, L. Hue, C. Proud, and M. Rider Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis Curr Biol 12 2002 1419 1423
34. M. Kodiha, and U. Stochaj Targeting AMPK for therapeutic intervention in type 2 diabetes C. Croniger, Medical Complications of Type 2 Diabetes 2011 InTech Rijeka (Croatia) doi: 10.5772/20930. Available from: http://www.intechopen.com/books/medical-complications-of-type-2-diabetes/targeting-ampk-for-therapeutic-intervention-in-type-2-diabetes.
35. J.M. Corton, J.G. Gillespie, S.A. Hawley, and D.G. Hardie 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 229 1995 558 565
36. D.G. Hardie, F.A. Ross, and S.A. Hawley AMP-activated protein kinase: a target for drugs both ancient and modern Chem Biol 19 2012 1222 1236
37. V.A. Narkar, M. Downes, R.T. Yu, E. Embler, Y.X. Wang, E. Banayo, M.M. Mihaylova, M.C. Nelson, Y. Zou, H. Juguilon, H. Kang, R.J. Shaw, and R.M. Evans AMPK and PPARdelta agonists are exercise mimetics Cell 134 2008 405 415
38. A.E. Decléves, Z. Zolkipli, J. Satriano, L. Wang, T. Nakayama, M. Rogac, T.P. Le, J.L. Nortier, M.G. Farquhar, R.K. Naviaux, and K. Sharma Regulation of lipid accumulation by AMP-activated kinase [corrected] in high fat diet-induced kidney injury Kidney Int 85 2014 611 623
39. M. Buzzai, R.G. Jones, R.K. Amaravadi, J.J. Lum, R.J. DeBerardinis, F. Zhao, B. Viollet, and C.B. Thompson Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth Cancer Res 67 2007 6745 6752
40. S. El Messaoudi, G.A. Rongen, and N.P. Riksen Metformin therapy in diabetes: the role of cardioprotection Curr Atheroscler Rep 15 2013 314
41. B. Viollet, B. Guigas, N. Sanz Garcia, J. Leclerc, M. Foretz, and F. Andreelli Cellular and molecular mechanisms of metformin: an overview Clin Sci (Lond) 122 2012 253 270
42. M.Y. El-Mir, V. Nogueira, E. Fontaine, N. Avéret, M. Rigoulet, and X. Leverve Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I J Biol Chem 275 2000 223 228
43. A. Vazquez-Martin, C. Oliveras-Ferraros, S. Cufí, B. Martin-Castillo, and J.A. Menendez Metformin and energy metabolism in breast cancer: from insulin physiology to tumour-initiating stem cells Curr Mol Med 10 2010 674 691
44. M.J. Lee, D. Feliers, M.M. Mariappan, K. Sataranatarajan, L. Mahimainathan, N. Musi, M. Foretz, B. Viollet, J.M. Weinberg, G.G. Choudhury, and B.S. Kasinath A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy Am J Physiol Renal Physiol 292 2007 F617 F627
45. S. Bamri-Ezzine, Z.J. Ao, I. Londoño, D. Gingras, and M. Bendayan Apoptosis of tubular epithelial cells in glycogen nephrosis during diabetes Lab Invest 83 2003 1069 1080
46. K. Sharma, S. Ramachandrarao, G. Qiu, H.K. Usui, Y. Zhu, S.R. Dunn, R. Ouedraogo, K. Hough, P. McCue, L. Chan, B. Falkner, and B.J. Goldstein Adiponectin regulates albuminuria and podocyte function in mice J Clin Invest 118 2008 1645 1656
47. P.G. Cammisotto, and M. Bendayan Adiponectin stimulates phosphorylation of AMP-activated protein kinase alpha in renal glomeruli J Mol Histol 39 2008 579 584
48. M. Lagouge, C. Argmann, Z. Gerhart-Hines, H. Meziane, C. Lerin, F. Daussin, N. Messadeq, J. Milne, P. Lambert, P. Elliott, B. Geny, M. Laakso, P. Puigserver, and J. Auwerx Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha Cell 127 2006 1109 1122
49. A. Brunet, L.B. Sweeney, J.F. Sturgill, K.F. Chua, P.L. Greer, Y. Lin, H. Tran, S.E. Ross, R. Mostoslavsky, H.Y. Cohen, L.S. Hu, H.L. Cheng, M.P. Jedrychowski, S.P. Gygi, D.A. Sinclair, F.W. Alt, and M.E. Greenberg Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase Science 303 2004 2011 2015
50. J.T. Rodgers, C. Lerin, W. Haas, S.P. Gygi, B.M. Spiegelman, and P. Puigserver Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1 Nature 434 2005 113 118
51. F. Yeung, J.E. Hoberg, C.S. Ramsey, M.D. Keller, D.R. Jones, R.A. Frye, and M.W. Mayo Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase Embo J 23 2004 2369 2380
52. C.C. Chang, C.Y. Chang, Y.T. Wu, J.P. Huang, T.H. Yen, and L.M. Hung Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase J Biomed Sci 18 2011 47
53. L.P. Yang, and G.M. Keating Fenofibric acid: in combination therapy in the treatment of mixed dyslipidemia Am J Cardiovasc Drugs 9 2009 401 409
54. N.M. Al-Rasheed, N.M. Al-Rasheed, H.A. Attia, M.A. Al-Amin, H.N. Al-Ajmi, I.H. Hasan, R.A. Mohamad, and N.A. Sinjilawi Renoprotective effects of fenofibrate via modulation of LKB1/AMPK mRNA expression and endothelial dysfunction in a rat model of diabetic nephropathy Pharmacology 95 2015 229 239
55. Y.A. Hong, J.H. Lim, M.Y. Kim, T.W. Kim, Y. Kim, K.S. Yang, H.S. Park, S.R. Choi, S. Chung, H.W. Kim, H.W. Kim, B.S. Choi, Y.S. Chang, and C.W. Park Fenofibrate improves renal lipotoxicity through activation of AMPK-PGC-1alpha in db/db mice PLoS One 9 2014 e96147
56. Y. Liu, D. Li, Y. Zhang, R. Sun, and M. Xia Anthocyanin increases adiponectin secretion and protects against diabetes-related endothelial dysfunction Am J Physiol Endocrinol Metab 306 2014 E975 E988
57. L. Valenti, P. Riso, A. Mazzocchi, M. Porrini, S. Fargion, and C. Agostoni Dietary anthocyanins as nutritional therapy for nonalcoholic fatty liver disease Oxid Med Cell Longev 2013 2013 145421
58. E.S. Koh, J.H. Lim, M.Y. Kim, S. Chung, S.J. Shin, B.S. Choi, H.W. Kim, S.Y. Hwang, S.W. Kim, C.W. Park, and Y.S. Chang Anthocyanin-rich Seoritae extract ameliorates renal lipotoxicity via activation of AMP-activated protein kinase in diabetic mice J Transl Med 13 2015 203
59. Z.A. Massy, L. Henaut, T.E. Larsson, and M.G. Vervloet Calcium-sensing receptor activation in chronic kidney disease: effects beyond parathyroid hormone control Semin Nephrol 34 2014 648 659
60. P. Thakore, and W.S. Ho Vascular actions of calcimimetics: role of Ca(2)(+) -sensing receptors versus Ca(2)(+) influx through L-type Ca(2)(+) channels Br J Pharmacol 162 2011 749 762
61. M. Bonomini, A. Giardinelli, C. Morabito, S. Di Silvestre, M. Di Cesare, N. Di Pietro, V. Sirolli, G. Formoso, L. Amoroso, M.A. Mariggió, and A. Pandolfi Calcimimetic R-568 and its enantiomer S-568 increase nitric oxide release in human endothelial cells PLoS One 7 2012 e30682
62. M. Okada-Iwabu, T. Yamauchi, M. Iwabu, T. Honma, K. Hamagami, K. Matsuda, M. Yamaguchi, H. Tanabe, T. Kimura-Someya, M. Shirouzu, H. Ogata, K. Tokuyama, K. Ueki, T. Nagano, A. Tanaka, S. Yokoyama, and T. Kadowaki A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity Nature 503 2013 493 499
63. W.L. Holland, and P.E. Scherer Cell biology. Ronning after the adiponectin receptors Science 342 2013 1460 1461
64. K.N. Ealey, J. Kaludjerovic, M.C. Archer, and W.E. Ward Adiponectin is a negative regulator of bone mineral and bone strength in growing mice Exp Biol Med (Maywood) 233 2008 1546 1553
65. T. Yamauchi, J. Kamon, H. Waki, Y. Terauchi, N. Kubota, K. Hara, Y. Mori, T. Ide, K. Murakami, N. Tsuboyama-Kasaoka, O. Ezaki, Y. Akanuma, O. Gavrilova, C. Vinson, M.L. Reitman, H. Kagechika, K. Shudo, M. Yoda, Y. Nakano, K. Tobe, R. Nagai, S. Kimura, M. Tomita, P. Froguel, and T. Kadowaki The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nat Med 7 2001 941 946
66. T.P. Combs, U.B. Pajvani, A.H. Berg, Y. Lin, L.A. Jelicks, M. Laplante, A.R. Nawrocki, M.W. Rajala, A.F. Parlow, L. Cheeseboro, Y.Y. Ding, R.G. Russell, D. Lindemann, A. Hartley, G.R. Baker, S. Obici, Y. Deshaies, M. Ludgate, L. Rossetti, and P.E. Scherer A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity Endocrinology 145 2004 367 383
67. D.C. Jin, I.S. Ha, N.H. Kim, S.W. Lee, J.S. Lee, S.R. Yoon, and B.S. Kim Brief report: renal replacement therapy in Korea, 2010 Kidney Res Clin Pract 31 2012 62 71
68. Y. Minokoshi, T. Alquier, N. Furukawa, Y.B. Kim, A. Lee, B. Xue, J. Mu, F. Foufelle, P. Ferré, M.J. Birnbaum, B.J. Stuck, and B.B. Kahn AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus Nature 428 2004 569 574
69. K. Burkewitz, Y. Zhang, and W.B. Mair AMPK at the nexus of energetics and aging Cell Metab 20 2014 10 25